Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 May;86(5):834-836.
doi: 10.1111/bcp.14262. Epub 2020 Mar 6.

Cobicistat: A case of mislabelled drug-drug interaction risk?

David M Burger  1 , Alexandra Calmy  2 , Catia Marzolini  3   4
Affiliations
Editorial

Cobicistat: A case of mislabelled drug-drug interaction risk?

David M Burger et al. Br J Clin Pharmacol. 2020 May.
No abstract available

Keywords: HIV/AIDS; cytochrome P450; drug interactions.

PubMed Disclaimer

Conflict of interest statement

C.M.: None. A.M. received unrestricted educational grant from MSD, ViiV Healthcare, Gilead Sciences Financial Support for the day Hospital (LIPO and metabolism) at the Geneva University Hospital: ViiV Healthcare, Gilead. D.B. received research grants by Merck, ViiV, Gilead, Janssen Consultation fee: Merck All invoices were sent by the financial department of Radboudumc, the employer of DM Burger.

References

    1. Walker WF, Hunter RB. Oral administration of procaine penicillin with and without benemid [p‐(DI‐n‐propylsulphamyl) benzoic acid]. Lancet. 1951;2(6673):104‐106. - PubMed
    1. Randall T. Cyclosporine‐ketoconazole combination offers promise in reducing antirejection therapy costs. JAMA. 1990;264(4):430‐431. - PubMed
    1. Lubberman FJE, van Erp NP, Ter Heine R, van Herpen CML. Boosting axitinib exposure with a CYP3A4 inhibitor, making axitinib treatment personal. Acta Oncol. 2017;56(9):1238‐1240. - PubMed
    1. Tseng A, Hughes CA, Wu J, Seet J, Phillips EJ. Cobicistat versus ritonavir: similar pharmacokinetic enhancers but some important differences. Ann Pharmacother. 2017;51(11):1008‐1022. - PMC - PubMed
    1. Gordon LA, Kumar P, Brooks KM, et al. Antiretroviral boosting agent cobicistat increases the pharmacokinetic exposure and anticoagulant effect of dabigatran in HIV‐negative healthy volunteers. Circulation. 2016;134(23):1909‐1911. - PMC - PubMed

Publication types